Inventor · disambiguated record
Maria L. Jaramillo
Also filed as: JARAMILLO MARIA · JARAMILLO MARIA L · JARAMILLO MARIA LUZ
9 granted patents·5 pending applications·21 citations·filing 2004–2023
81Inventor score
Files withNAT RES COUNCIL CANADA9TIKHOMIROV ILIA ALEXANDRE2CA NAT RESEARCH COUNCIL1GILEAD SCIENCES INC1ZWAAGSTRA JOHN C1
Top patents by PatentIndex Score
14 records- 0186US12391743B2TGF-β-receptor ectodomain fusion molecules and uses thereofNAT RES COUNCIL CANADA·Filed 2021·Granted Aug 19, 2025·1 cites·14 claims
- 0278US8987417B2Covalently dimerized bivalent binding agentsZWAAGSTRA JOHN C·Filed 2011·Granted Mar 24, 2015·6 cites·8 claims
- 0374US7786261B2Coiled-coil fusion proteins comprising cell receptor domainsCA NAT RESEARCH COUNCIL·Filed 2004·Granted Aug 31, 2010·13 cites·16 claims
- 0467US2024076389A1Axl-specific antibodies and uses thereofNAT RES COUNCIL CANADA·Filed 2023·Application pending·0 cites
- 0562US11739154B2AXL-specific antibodies and uses thereofNAT RES COUNCIL CANADA·Filed 2018·Granted Aug 29, 2023·0 cites·23 claims
- 0661US10208129B2Antibodies selective for cells presenting ErbB2 at high densityTIKHOMIROV ILIA ALEXANDRE·Filed 2011·Granted Feb 19, 2019·1 cites·12 claims
- 0755US12084510B2Antibodies selective for cells presenting EGFR at high densityGILEAD SCIENCES INC·Filed 2020·Granted Sep 10, 2024·0 cites·25 claims
- 0853US12392777B2Antibody variants with pH-dependent antigen binding for selective targeting of solid tumorsNAT RES COUNCIL CANADA·Filed 2020·Granted Aug 19, 2025·0 cites·20 claims
- 0953US2024408249A1Egfrviii-targeted compounds and uses thereofNAT RES COUNCIL CANADA·Filed 2022·Application pending·0 cites
- 1052US2019194349A1Antibodies selective for cells presenting erbb2 at high densityNAT RES COUNCIL CANADA·Filed 2018·Application pending·0 cites
- 1151US11591408B2Antibody glycoconjugates and methods of production and useNAT RES COUNCIL CANADA·Filed 2018·Granted Feb 28, 2023·0 cites·19 claims
- 1248US2024400697A1Humanized anti-egfr viii antibodies and antigen-binding fragments thereofNAT RES COUNCIL CANADA·Filed 2021·Application pending·0 cites
- 1344US2020231652A1Tgf-b-receptor ectodomain fusion molecules and uses thereofNAT RES COUNCIL CANADA·Filed 2016·Application pending·0 cites
- 1438US10570211B2Antibodies selective for cells presenting EGFR at high densityTIKHOMIROV ILIA ALEXANDRE·Filed 2012·Granted Feb 25, 2020·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →